Attached files
| file | filename |
|---|---|
| 10-Q - SKYSTAR BIO-PHARMACEUTICAL CO | v185379_10q.htm |
| EX-31.2 - SKYSTAR BIO-PHARMACEUTICAL CO | v185379_ex31-2.htm |
| EX-31.1 - SKYSTAR BIO-PHARMACEUTICAL CO | v185379_ex31-1.htm |
| EX-32.2 - SKYSTAR BIO-PHARMACEUTICAL CO | v185379_ex32-2.htm |
Exhibit
32.1
CERTIFICATION
In
connection with the periodic report of Skystar Bio-Pharmaceutical Company (the
“Company”) on Form 10-Q for the quarter ending March 31, 2010, as filed with the
Securities and Exchange Commission (the “Report”), I, Weibing Lu, Chief Executive
Officer (Principal Executive Officer) of the Company, hereby certify as of the
date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the
United States Code, that to the best of my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company at the dates
and for the periods indicated.
|
Date: May
17, 2010
|
/s/ Weibing Lu
|
|
|
Weibing Lu
|
||
|
Chief
Executive Officer
|
||
|
(Principal
Executive Officer)
|